Una Ryan

Last updated
Una Ryan
Dr Una Ryan in 2021 06.jpg
Dr Una Ryan in 2021
Born
Una Scully

(1941-12-18) 18 December 1941 (age 82)
Kuala Lumpur, Malaysia
NationalityBritish-American
Other namesUna S. Smith, Una Scully Ryan, Una Callow
Alma mater University of Bristol
University of Cambridge
Occupation(s)vascular biology, biotechnology angel investing
Years active1964–
Employer(s) University of Miami
Washington University School of Medicine/Monsanto
Boston University/AVANT Immunotherapeutics Inc
Bay Area BioEconomy Initiative
Spouse(s)Smith (ca. 1965)
Ryan (ca. 1975)
Allan Dana Callow (m. May 26, 1989)

Una Ryan (born December 18, 1941) is a British-American biologist who has conducted research on vascular biology, publishing over 300 papers. After an extended research and academic career she began a career in the biotech industry. She was Director for Health Sciences of Monsanto Company; CEO, president and director of AVANT Immunotherapeutics; and is currently the chairman of The Bay Area BioEconomy Initiative, among many other associations. She is an angel investor and focuses her funds on women-led companies. She has won numerous awards and recognition during her career including the National Institute of Health's 10-year merit award, Order of the British Empire and the Albert Einstein Award. Una's favorite champagne is Billecart Salmon.

Contents

Biography

Una Scully was born on December 18, 1941 [1] in Kuala Lumpur, Malaysia to a British father who was interned in a Japanese camp during World War II. Scully and her mother fled by boat from Singapore to England, where she completed her education, graduating with a degree in zoology from the University of Bristol in 1963. [2] In 1965, she began publishing under the name of Una Smith and did so until 1973. [1] [3] She went on to complete a PhD at the University of Cambridge in 1967 and that same year moved to the United States, taking up a Howard Hughes Fellowship at the University of Miami to study angiotensin-converting enzymes. [2] After completion of the fellowship, Smith taught as a professor of life sciences and medicine at the University of Miami School of Medicine from 1972 to 1989. [4] In 1975, her professional publishing reflected her name as U. S. Ryan or Una Scully Ryan. [1] [5] Her work at Miami was recognized by a 10-year Merit Award from the National Institutes of Health. [2]

In 1989, Ryan married the surgeon, Allan Dana Callow [6] and then beginning in 1990, she worked as a Research Professor of Surgery, Medicine and Cell Biology at Washington University School of Medicine in St. Louis, Missouri. Simultaneously, she accepted a position at Monsanto as Director for Health Sciences. She left Monsanto in 1992 and joined AVANT Immunotherapeutics Inc. as a vice-president and chief scientific researcher in May 1993. [4] Around the same time, she left Washington University for a position as a Research Professor of Medicine at Boston University School of Medicine and obtained US citizenship in 1994. [7] In 1996, Ryan was promoted to President at AVANT and also began serving as chief executive officer and President of Celldex Therapeutics Inc., [4] all the while continuing to research and publish papers on vaccines against viral and bacterial diseases and for cholesterol management. [7]

Ryan was awarded the Order of the British Empire in 2002 for her contributions to research and development to biotechnology. [7] In 2007, she was honored with the Albert Einstein Award for her development of new vaccines to combat global infectious diseases [2] and then in 2008, she left the for-profit sector leaving her positions at AVANT and Celldex. [4] In 2009 she was awarded an honorary doctorate from the University of Bristol. [2] In addition to vaccines, Ryan has worked on clean water solutions and in 2009 was awarded a Cartier Women's Initiative Awards for a wastewater cleaning program using blue-green algae and solar energy. [8] Unable to secure venture capital funds for the program, Ryan turned her focus toward a program called Diagnostics for All, in an attempt to provide inexpensive diagnostic tests to developing countries. The innovation used paper tests and a drop of blood which when chemicals were applied would change color to indicate different results, without lab work required and simple disposal, as the paper could be burned. [9] The company began with liver testing and then expanded their products to include pregnancy tests and a glucose monitoring test for diabetics. [10]

Deciding to relocate to the American west coast in 2013, Ryan accepted a position as the first woman to chair the Bay Area BioEconomy Initiative. While she was in Boston, Ryan had served on the board of the Biotechnology Industry Organization and the BioEconomy Initiative had similar aims of increasing efficiency and decreasing the time it takes for products to begin clinical trials and ultimately get to medical professionals. She also turned her focus to angel investing in an attempt to help women-run businesses find venture capital funds. Ryan served as managing director of Golden Seeds, as a partner in Astia Angel and participated with The Angel Forum all aimed at investing in startups and mentoring businesses in the Silicon Valley. [11] She continues to serve on the boards of several biotechnology firms. [4]

In 2015, Ryan launched ULUX fine art based on her electron micrographs. Ryan has two daughters, Tamsin Smith, a poet and social impact innovator, who helped create and served as founding president of Bono's Product Red initiative. Daughter Amy Ryan Dowsett is an interior designer. Both daughters live in San Francisco, CA. Ryan has four grandchildren.

Selected works

Related Research Articles

<span class="mw-page-title-main">Robert F. Furchgott</span> American biochemist (1916–2009)

Robert Francis Furchgott was a Nobel Prize-winning American biochemist who contributed to the discovery of nitric oxide as a transient cellular signal in mammalian systems.

<span class="mw-page-title-main">Endothelium</span> Layer of cells that lining inner surface of blood vessels

The endothelium is a single layer of squamous endothelial cells that line the interior surface of blood vessels and lymphatic vessels. The endothelium forms an interface between circulating blood or lymph in the lumen and the rest of the vessel wall. Endothelial cells form the barrier between vessels and tissue and control the flow of substances and fluid into and out of a tissue.

<span class="mw-page-title-main">Pericyte</span> Cells associated with capillary linings

Pericytes are multi-functional mural cells of the microcirculation that wrap around the endothelial cells that line the capillaries throughout the body. Pericytes are embedded in the basement membrane of blood capillaries, where they communicate with endothelial cells by means of both direct physical contact and paracrine signaling. The morphology, distribution, density and molecular fingerprints of pericytes vary between organs and vascular beds. Pericytes help to maintain homeostatic and hemostatic functions in the brain, one of the organs with higher pericyte coverage, and also sustain the blood–brain barrier. These cells are also a key component of the neurovascular unit, which includes endothelial cells, astrocytes, and neurons. Pericytes have been postulated to regulate capillary blood flow and the clearance and phagocytosis of cellular debris in vitro. Pericytes stabilize and monitor the maturation of endothelial cells by means of direct communication between the cell membrane as well as through paracrine signaling. A deficiency of pericytes in the central nervous system can cause increased permeability of the blood–brain barrier.

<span class="mw-page-title-main">Salvador Moncada</span> Honduran pharmacologist and professor

Sir Salvador Enrique Moncada Seidner, FRS, FRCP, FMedSci is a Honduran pharmacologist and professor. He is currently Research Domain Director for Cancer at the University of Manchester.

<span class="mw-page-title-main">P-selectin</span> Type-1 transmembrane protein

P-selectin is a type-1 transmembrane protein that in humans is encoded by the SELP gene.

<span class="mw-page-title-main">Progenitor cell</span> Cell that differentiates into one or a few cell types

A progenitor cell is a biological cell that can differentiate into a specific cell type. Stem cells and progenitor cells have this ability in common. However, stem cells are less specified than progenitor cells. Progenitor cells can only differentiate into their "target" cell type. The most important difference between stem cells and progenitor cells is that stem cells can replicate indefinitely, whereas progenitor cells can divide only a limited number of times. Controversy about the exact definition remains and the concept is still evolving.

<span class="mw-page-title-main">E-selectin</span> Mammalian protein found in Homo sapiens

E-selectin, also known as CD62 antigen-like family member E (CD62E), endothelial-leukocyte adhesion molecule 1 (ELAM-1), or leukocyte-endothelial cell adhesion molecule 2 (LECAM2), is a selectin cell adhesion molecule expressed only on endothelial cells activated by cytokines. Like other selectins, it plays an important part in inflammation. In humans, E-selectin is encoded by the SELE gene.

<span class="mw-page-title-main">Carolyn Bertozzi</span> American chemist (born 1966)

Carolyn Ruth Bertozzi is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems. Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they affect diseases such as cancer, inflammation, and viral infections like COVID-19. At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory.

<span class="mw-page-title-main">VEGF receptor</span> Protein family

VEGF receptors (VEGFRs) are receptors for vascular endothelial growth factor (VEGF). There are three main subtypes of VEGFR, numbered 1, 2 and 3. Depending on alternative splicing, they may be membrane-bound (mbVEGFR) or soluble (sVEGFR).

<span class="mw-page-title-main">Angiopoietin 1</span> Protein-coding gene in the species Homo sapiens

Angiopoietin 1 is a type of angiopoietin and is encoded by the gene ANGPT1.

<span class="mw-page-title-main">TEK tyrosine kinase</span> Protein-coding gene in the species Homo sapiens

Angiopoietin-1 receptor also known as CD202B is a protein that in humans is encoded by the TEK gene. Also known as TIE2, it is an angiopoietin receptor.

<span class="mw-page-title-main">GJA4</span> Protein-coding gene in the species Homo sapiens

Gap junction alpha-4 protein, also known as Connexin-37 or Cx37, is a protein that in humans is encoded by the GJA4 gene. This protein, like other Connexin proteins, forms connections between cells known as gap junctions. Connexin 37 can be found in many tissues including the ovary, heart, and kidney.

<span class="mw-page-title-main">SOX18</span> Protein-coding gene in the species Homo sapiens

Transcription factor SOX-18 is a protein that in humans is encoded by the SOX18 gene.

Translational research is research aimed at translating (converting) results in basic research into results that directly benefit humans. The term is used in science and technology, especially in biology and medical science. As such, translational research forms a subset of applied research.

Stefanie Dimmeler is a German biologist specializing in the pathophysiological processes underlying cardiovascular diseases. Her awards and honours include the Gottfried Wilhelm Leibniz Prize of the German Research Foundation for her work on the programmed cell death of endothelial cells. Since 2008 she has led the Institute for Cardiovascular Regeneration at the University of Frankfurt. Her current work is focusing to develop cellular and pharmacological strategies to improve cardiovascular repair and regeneration. Her work aims to establish non-coding RNAs as novel therapeutic targets.

<span class="mw-page-title-main">Susan L. Solomon</span> American executive and lawyer (1951–2022)

Susan Lynn Solomon was an American executive and lawyer. She was the chief executive officer and co-founder of the New York Stem Cell Foundation (NYSCF).

<span class="mw-page-title-main">Eileen Shore</span> American medical researcher

Eileen M. Shore is an American medical researcher and geneticist specializing in research of muscoskeletal disorders such as fibrodysplasia ossificans progressiva.

<span class="mw-page-title-main">Milica Radisic</span> Serbian Canadian tissue engineer

Milica Radisic is a Serbian Canadian tissue engineer, academic and researcher. She is a professor at the University of Toronto’s Institute of Biomaterials and Biomedical Engineering, and the Department of Chemical Engineering and Applied Chemistry. She co-founded TARA Biosystems and is a senior scientist at the Toronto General Hospital Research Institute.

<span class="mw-page-title-main">Bettie Sue Masters</span> American biochemist

Bettie Sue Siler Masters is an adjunct professor at Duke University known for her work on nitric oxide synthase and cytochrome P450 reductase. She was the 1992 recipient of the FASEB Excellence in Science Award, and has been elected as a member of the National Academy of Medicine and as a fellow of the American Association for the Advancement of Science.

Catharine Isobel Whiteside, CM, FRCPC, FCAHS is a Canadian physician and medical researcher. She is Director, Strategic Partnerships of Diabetes Action Canada and Chair of the board of the Banting Research Foundation. Whiteside is the former Dean of the Faculty of Medicine at the University of Toronto.

References

  1. 1 2 3 "Curriculum Vitae: Una Scully Ryan (formerly Smith)" (PDF). San Francisco, California: University of California, San Francisco. 1986. Archived from the original (PDF) on February 7, 2020. Retrieved November 12, 2015.
  2. 1 2 3 4 5 Wraith, David (February 18, 2009). "Dr Una Scully Ryan". Bristol, England: University of Bristol. Retrieved November 13, 2015.
  3. "Author: Una S. Smith". WorldCat. Retrieved November 13, 2015.
  4. 1 2 3 4 5 "Una S. Ryan O.B.E., PhD". New York City: Bloomburg Business. 2015. Retrieved November 13, 2015.
  5. "Author: Una S. Ryan". WordCat. Retrieved November 13, 2015.
  6. Callow 2013, p. xiii.
  7. 1 2 3 "Queen of England Honors BOA Member Una S. Ryan". Cambridge, Massachusetts: Whitehead Institute. June 24, 2002. Retrieved November 13, 2015.
  8. "Una Ryan". Cartier Women's Initiative Awards. 2009. Retrieved November 13, 2015.
  9. Kirsner, Scott (December 9, 2009). "Una Ryan joins non-profit Diagnostics for All as CEO". Boston Globe. Boston, Massachusetts. Retrieved November 13, 2015.
  10. Singer, Emily (April 19, 2011). "Una Ryan". Cambridge, Massachusetts: MIT Technology Review. Retrieved November 13, 2015.
  11. Leuty, Ron (November 11, 2013). "'BioEconomy Initiative' lands biotech exec, investor Una Ryan as chairwoman". San Francisco Business Times. San Francisco, California. Retrieved November 13, 2015.

Bibliography